Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects.Published in:PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204974By:McClure, Matthew W.;Berliba, Elina;Tsertsvadze, Tengiz;Streinu-Cercel, Adrian;Vijgen, Leen;Astruc, Béatrice;Patat, Alain;Westland, Christopher;Chanda, Sushmita;Zhang, Qingling;Kakuda, Thomas N.;Vuong, Jennifer;Khorlin, Nick;Beigelman, Leonid;Blatt, Lawrence M.;Fry, JohnPublication type:Article